Abstract
Introduction
Postoperative pain remains the most common challenge following inpatient and outpatient surgeries, and, therefore, opioid analgesics are widely used during the perioperative period. The aim of this study is to examine the efficiency of transversus abdominis plane (TAP) block using liposomal bupivacaine in reducing the use of opioid analgesics during the perioperative period of bariatric procedures.
Material and Methods
A retrospective chart review was performed on 191 patients who underwent a laparoscopic bariatric procedure between September 13, 2017, and February 26, 2018. A total of 97 patients received TAP block with liposomal bupivacaine, and 94 patients did not receive TAP block.
Results
Baseline patient characteristics were comparable between the two groups. The mean age was 43.7 and 41.1 years, and the mean preoperative body mass index (BMI) was 45.6 and 46.1 kg/m2 in TAP and non-TAP groups, respectively. In the TAP group, 65 patients (69.2%) received intravenous (IV) hydromorphone or morphine while 93 (95.9%) did in the non-TAP group (p < 0.0001). In the TAP group, 44 (46.8%) received oral opioid analgesic while 73 (75.3%) did in the non-TAP group (p < 0.0001). The odds of receiving IV hydromorphone or morphine for TAP group was about 0.10 times the corresponding odds for non-TAP group, and the odds of receiving oral opioid analgesic for the TAP group was about 0.29 times the corresponding odds for the non-TAP group.
Conclusion
The use of preoperative TAP block with liposomal bupivacaine significantly decreased the use of IV and oral opioid analgesics. A larger prospective study may be needed to further validate the results.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartels K, Mayes LM, Dingmann C, et al. Opioid use and storage patterns by patients after hospital discharge following surgery. PLoS One. 2016;11(1):e0147972.
Koepke EJ, Manning EL, Miller TE, et al. The rising tide of opioid use and abuse: the role of the anesthesiologist. Perioper Med (Lond). 2018;7:16.
Beloeil H, Laviolle B, Menard C, et al. POFA trial study protocol: a multicentre, double-blind, randomised, controlled clinical trial comparing opioid-free versus opioid anaesthesia on postoperative opioid-related adverse events after major or intermediate non-cardiac surgery. BMJ Open. 2018;8(6):e020873.
Singh R, Kumar N, Jain A, et al. Addition of clonidine to bupivacaine in transversus abdominis plane block prolongs postoperative analgesia after cesarean section. J Anaesthesiol Clin Pharmacol. 2016;32(4):501–4.
Ma N, Duncan JK, Scarfe AJ, et al. Clinical safety and effectiveness of transversus abdominis plane (TAP) block in post-operative analgesia: a systematic review and meta-analysis. J Anesth. 2017;31(3):432–52.
Albrecht E, Kirkham KR, Endersby RV, et al. Ultrasound-guided transversus abdominis plane (TAP) block for laparoscopic gastric-bypass surgery: a prospective randomized controlled double-blinded trial. Obes Surg. 2013;23(8):1309–14.
Saber AA, Lee YC, Chandrasekaran A, et al. Efficacy of transversus abdominis plane (TAP) block in pain management after laparoscopic sleeve gastrectomy (LSG): a double-blind randomized controlled trial. Am J Surg. 2019;217:126–32.
Wassef M, Lee DY, Levine JL, et al. Feasibility and analgesic efficacy of the transversus abdominis plane block after single-port laparoscopy in patients having bariatric surgery. J Pain Res. 2013;6:837–41.
Sinha A, Jayaraman L, Punhani D. Efficacy of ultrasound-guided transversus abdominis plane block after laparoscopic bariatric surgery: a double blind, randomized, controlled study. Obes Surg. 2013;23(4):548–53.
Mittal T, Dey A, Siddhartha R, et al. Efficacy of ultrasound-guided transversus abdominis plane (TAP) block for postoperative analgesia in laparoscopic gastric sleeve resection: a randomized single blinded case control study. Surg Endosc. 2018;32:4985–9.
Ruiz-Tovar J, Garcia A, Ferrigni C, et al. Laparoscopic-guided transversus abdominis plane (TAP) block as part of multimodal analgesia in laparoscopic Roux-en-Y gastric bypass within an enhanced recovery after surgery (ERAS) program: a prospective randomized clinical trial. Obes Surg. 2018;28(11):3374–9.
Candiotti K. Liposomal bupivacaine: an innovative nonopioid local analgesic for the management of postsurgical pain. Pharmacotherapy. 2012;32(9 Suppl):19S–26S.
Bhakta A, Glotzer O, Ata A, et al. Analgesic efficacy of laparoscopic-guided transverse abdominis plane block using liposomal bupivacaine in bariatric surgery. Am J Surg. 2018;215(4):643–6.
Said AM, Balamoun HA. Continuous transversus abdominis plane blocks via laparoscopically placed catheters for bariatric surgery. Obes Surg. 2017;27(10):2575–82.
Acknowledgements
The authors would like to thank Dr. Kevin Funez, and other anesthesiologists in the Wolverine Anesthesia Consultants Inc. for performing ultrasound-guided TAP for our patients.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Authors Moon, Lastrapes, Wier, Nakajima, Gaskins, Teixeira, and Jawad have no commercial associations that might be a conflict of interest in relation to this article.
Ethical Approval
For this type of study, formal consent is not required.
Informed Consent
Does not apply.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Moon, R.C., Lastrapes, L., Wier, J. et al. Preoperative Transversus Abdominis Plane (TAP) Block with Liposomal Bupivacaine for Bariatric Patients to Reduce the Use of Opioid Analgesics. OBES SURG 29, 1099–1104 (2019). https://doi.org/10.1007/s11695-018-03668-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-018-03668-5